EPT Disclosure
17 May 2006 - 9:20PM
UK Regulatory
RNS Number:1152D
Morgan Stanley Securities Ld(EPT)
17 May 2006
FORM 38.5
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
(Rule 38.5 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of exempt principal trader Morgan Stanley Securities Limited
Company dealt in Cambridge Antibody Technology Group Plc
Class of relevant security to which the Ordinary Shares
dealings being disclosed relate (Note 1)
Date of dealing 16 May 2006
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities purchased Highest price paid GBP Lowest price paid GBP
14,035 13.00 12.97
Total number of securities sold Highest price received GBP Lowest price paid received GBP
33,355 13.00 12.98
(b) Derivatives transactions (other than options)
Product name, Long/short Number of securities Price per unit GBP
e.g. CFD
CFD SHORT 31,549 13.00
CFD LONG 2,800 13.01
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating
to the voting rights of any relevant securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
NONE
Date of disclosure 17 May 2006
Contact name Mandeep Bhandal
Telephone number 020 7677 5468
Name of offeree/offeror with which associated Cambridge Antibody Technology Group Plc
Specify category and nature of associate status 6 Advisor
Notes
The Notes on Form 38.5 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMILFFLEIIDLIR
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024